Gilead (NASDAQ:GILD) had its estimates and price target increased by Jefferies (JEF) after the approval of the stribild quad pill, as well as higher pricing announced for the future. A $55 price target was set with a hold rating.
Shares are higher by about one percent.
Ingersoll-Rand (NYSE:IR) had its price target incrased by UBS due to strong HVAC business. A $54 price target was set with a buy rating.
Shares are higher by about a quarter of a percent.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.